PART I Overview We are a global oncology company with a proprietary platform technology called Tumor Treating Fields ("TTFields"), which are electric fields that exert physical forces to kill cancer cells. Our therapy is delivered through a medical device. Our key priorities are to drive commercial adoption of Optune Gio , Optune Lua , and Optune Pax , our commercial TTFields therapy devices, obtain regulatory approval to market TTFields therapy devices in new indications, such as brain metastas...
Q2 FY2026 — expected 2026-09-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001645113-26-000017 | EDGAR | 68K words |
| 2025-02-27 | 2024-12-31 | 0001645113-25-000002 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0001645113-24-000006 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0001645113-23-000023 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001645113-22-000011 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001645113-21-000017 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001645113-20-000025 | EDGAR | — |
| 2019-02-28 | 2018-12-31 | 0001564590-19-005146 | EDGAR | — |
| 2018-02-22 | 2017-12-31 | 0001564590-18-002766 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-23 | 2026-06-30 | 0001645113-26-000062 | EDGAR | — |
| 2025-10-30 | 2025-09-30 | 0001645113-25-000042 | EDGAR | 18K words |
| 2025-07-24 | 2025-06-30 | 0001645113-25-000029 | EDGAR | — |
| 2025-04-24 | 2025-03-31 | 0001645113-25-000008 | EDGAR | — |
| 2024-10-30 | 2024-09-30 | 0001645113-24-000031 | EDGAR | — |
| 2024-07-25 | 2024-06-30 | 0001645113-24-000019 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0001645113-24-000013 | EDGAR | — |
| 2023-10-26 | 2023-09-30 | 0001645113-23-000047 | EDGAR | — |
| 2023-07-27 | 2023-06-30 | 0001645113-23-000044 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001645113-23-000037 | EDGAR | — |
| 2022-10-27 | 2022-09-30 | 0001645113-22-000091 | EDGAR | — |
| 2022-07-28 | 2022-06-30 | 0001645113-22-000067 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-23 | 0001645113-26-000063 | EDGAR | — |
| 2026-03-26 | 0001645113-26-000023 | EDGAR | 1K words |
| 2026-02-26 | 0001645113-26-000018 | EDGAR | — |
| 2026-02-24 | 0001645113-26-000013 | EDGAR | — |
| 2026-02-11 | 0001645113-26-000010 | EDGAR | — |
| 2026-02-05 | 0001645113-26-000007 | EDGAR | — |
| 2026-01-12 | 0001645113-26-000003 | EDGAR | — |
| 2025-12-01 | 0001645113-25-000045 | EDGAR | — |
| 2025-10-30 | 0001645113-25-000043 | EDGAR | — |
| 2025-09-15 | 0001645113-25-000037 | EDGAR | — |
173 total filings indexed. 142 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001645113 |
| Ticker | NVCR |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Website | https://www.novocure.com |
| Listed | 2015-10-02 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NVCR (~200 tokens, structured JSON with cryptographic provenance)